Anzeige
Mehr »
Login
Freitag, 26.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Geheimtipp: Rasanter Aufstieg, Branchenrevolution und Jahresumsatz von 50 Mio. $
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
404 Leser
Artikel bewerten:
(2)

Nelipak Healthcare Packaging: Nelipak Appoints Roger Prevot as Chief Executive Officer

CRANSTON, R.I., Oct. 11, 2019. ("Nelipak"), a global leader in rigid and flexible packaging for the medical device and pharmaceutical sectors, announced today that Roger Prevot has been named the company's Chief Executive Officer. Prevot, who has been Chairman of the Board of Directors since the acquisition of Nelipak ("Kohlberg") earlier this year, brings to Nelipak an extensive track record of senior leadership experience in the packaging industry, and is a Partner of Kohlberg. Prevot's previous roles include President and Chief Operating Officer of Graham Packaging, Chief Executive Officer of Packaging Dynamics Corporation, Chairman of the Board of Spectrum Plastics Group and Chairman of the Board of Cadence, Inc.

Prevot stated, "I look forward to leading Nelipak into the next phase of its development as the legacy Nelipak business is integrated with the former European Healthcare Packaging business of Bemis Corporation."

Prevot assumes this role from Michael Kelly, Nelipak's current Chief Executive Officer. Under Kelly's leadership, Nelipak grew both organically and via acquisition and matured into a global leader in its served markets. Having substantially completed his objective to position Nelipak for the next phase of its development, Kelly is retiring.

Kelly commented, "I am proud of the accomplishments we have achieved together at Nelipak and the recent sale to Kohlberg. Roger's distinguished track record, together with his strong professional and personal values, make him an outstanding successor to lead Nelipak into the future. I wish Roger and the people of Nelipak much continued success in the years to come."

Seth H. Hollander, Partner of Kohlberg, commented, "On behalf of the Board of Directors of Nelipak, I wish to sincerely thank Mike for his distinguished service to the company. Mike was instrumental in building a foundation for sustained growth at Nelipak." Hollander continued, "As Chairman, Roger has been instrumental in the creation of the current Nelipak and its plan for transformational initiatives going forward. As a result of his vision, Nelipak is well-positioned for continued excellence in innovation and customer service as well as growth execution."

For further information on Nelipak and its various products, please visit www.nelipak.com.

About Nelipak Healthcare Packaging

With facilities in Cranston, RI; Whitehall, PA; Phoenix, AZ; Venray, the Netherlands; Galway, Ireland; Clara, Ireland; Derry, Northern Ireland; Elsham, United Kingdom; Humacao, Puerto Rico; and San Jose, Costa Rica, Nelipak Healthcare Packaging designs, develops and manufactures custom packaging products that provide superior protection for medical devices and pharmaceuticals. Nelipak Healthcare Packaging customers consist of some of the largest and most reputable medical device and pharmaceutical companies in the world. With over 1,400 employees worldwide, Nelipak is focused on delivering superior quality and customer experience through world class manufacturing at each of its locations.

Nelipak Healthcare Packaging is a trade name of Nelipak Corporation

About Kohlberg & Company, LLC

Kohlberg & Company, LLC.

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2019 GlobeNewswire (Europe)
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.